Department of Oncology, University Hospital, SE-701 85, Örebro, Sweden.
Int J Oncol. 2011 May;38(5):1465-74. doi: 10.3892/ijo.2011.947. Epub 2011 Feb 17.
We studied the association between use of mobile and cordless phones and malignant brain tumours. Pooled analysis was performed of two case-control studies on patients with malignant brain tumours diagnosed during 1997-2003 and matched controls alive at the time of study inclusion and one case-control study on deceased patients and controls diagnosed during the same time period. Cases and controls or relatives to deceased subjects were interviewed using a structured questionnaire. Replies were obtained for 1,251 (85%) cases and 2,438 (84%) controls. The risk increased with latency period and cumulative use in hours for both mobile and cordless phones. Highest risk was found for the most common type of glioma, astrocytoma, yielding in the >10 year latency group for mobile phone use odds ratio (OR) = 2.7, 95% confidence interval (CI) = 1.9-3.7 and cordless phone use OR = 1.8, 95% CI = 1.2-2.9. In a separate analysis, these phone types were independent risk factors for glioma. The risk for astrocytoma was highest in the group with first use of a wireless phone before the age of 20; mobile phone use OR = 4.9, 95% CI = 2.2-11, cordless phone use OR = 3.9, 95% CI = 1.7-8.7. In conclusion, an increased risk was found for glioma and use of mobile or cordless phone. The risk increased with latency time and cumulative use in hours and was highest in subjects with first use before the age of 20.
我们研究了使用移动电话和无绳电话与恶性脑肿瘤之间的关联。对三项病例对照研究进行了汇总分析,这些研究的对象是在 1997 年至 2003 年间诊断出患有恶性脑肿瘤的患者和与之相匹配的在研究纳入时存活的对照者,以及一项对在同一时期诊断出患有恶性脑肿瘤的已故患者和对照者的病例对照研究。使用结构化问卷对病例和对照者或已故对象的亲属进行了访谈。对 1251 名(85%)病例和 2438 名(84%)对照者作出了答复。移动电话和无绳电话的潜伏期和累积使用时间越长,风险越高。最常见的胶质瘤风险最高,在潜伏期>10 年的组中,移动电话使用比值比(OR)为 2.7,95%置信区间(CI)为 1.9-3.7,无绳电话使用 OR 为 1.8,95%CI 为 1.2-2.9。在单独的分析中,这些电话类型是胶质瘤的独立危险因素。在 20 岁之前首次使用无线电话的组中,星形细胞瘤的风险最高;移动电话使用 OR = 4.9,95%CI = 2.2-11,无绳电话使用 OR = 3.9,95%CI = 1.7-8.7。总之,发现使用移动电话或无绳电话与胶质瘤风险增加有关。风险随潜伏期时间和累积使用小时数而增加,在 20 岁之前首次使用的患者中风险最高。